JPH0755941B2 - Method for producing thiadiazolylacetic acid - Google Patents

Method for producing thiadiazolylacetic acid

Info

Publication number
JPH0755941B2
JPH0755941B2 JP12923486A JP12923486A JPH0755941B2 JP H0755941 B2 JPH0755941 B2 JP H0755941B2 JP 12923486 A JP12923486 A JP 12923486A JP 12923486 A JP12923486 A JP 12923486A JP H0755941 B2 JPH0755941 B2 JP H0755941B2
Authority
JP
Japan
Prior art keywords
salt
acid
added
amino
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP12923486A
Other languages
Japanese (ja)
Other versions
JPS62286979A (en
Inventor
武夫 金井
恵三 高柳
康秀 田中
淳 小岩
真一 遠藤
勝彦 佐藤
誠一郎 野本
功 杉山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP12923486A priority Critical patent/JPH0755941B2/en
Publication of JPS62286979A publication Critical patent/JPS62286979A/en
Publication of JPH0755941B2 publication Critical patent/JPH0755941B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Description

【発明の詳細な説明】 〔発明の目的〕 本発明は抗菌剤の中間体の製造方法に関するものであ
る。
DETAILED DESCRIPTION OF THE INVENTION [Object of the Invention] The present invention relates to a method for producing an intermediate of an antibacterial agent.

特開昭57-158769号公報には,7−アシルアミノセファロ
スポリン化合物を製造するためのアシル化剤として有用
なチアジアゾリル酢酸誘導体の製造方法が示されてい
る。この方法は,対応するアセトニトリル体を塩基の存
在下に加水分解する方法であるが,副反応物が生成して
収率が30%以下と非常に低く,工業的に満足できる方法
とはいえない。
JP-A-57-158769 discloses a method for producing a thiadiazolylacetic acid derivative useful as an acylating agent for producing a 7-acylaminocephalosporin compound. This method is a method of hydrolyzing the corresponding acetonitrile compound in the presence of a base, but the yield is very low at 30% or less due to the formation of side reaction products, and it cannot be said to be an industrially satisfactory method. .

そこで,本発明者等は,チアジアゾリル酢酸誘導体の工
業的製造方法について研究した結果,対応する新規チア
ジアゾリルアセトアミド誘導体を加水分解することによ
り収率よく目的物が得られることを見い出し,本発明を
完成した。
Therefore, the present inventors have studied the industrial production method of the thiadiazolylacetic acid derivative, and as a result, found that the desired product can be obtained in good yield by hydrolyzing the corresponding novel thiadiazolylacetamide derivative, and completed.

したがって,本発明の目的は抗菌剤の中間体として有用
なチアジアゾリル酢酸誘導体の新規な製造方法を提供す
ることにある。
Therefore, an object of the present invention is to provide a novel method for producing a thiadiazolylacetic acid derivative useful as an intermediate for an antibacterial agent.

〔発明の構成〕[Structure of Invention]

本発明は一般式: 〔式中,R1は低級アルキル基,R2は保護基で保護されて
いてもよいアミノ基を示す〕で表わされる化合物または
その塩を塩基の存在下で加水分解し,必要により保護基
を脱離することを特徴とする一般式: 〔式中,R1およびR2は前記の定義に同じ〕で表わされる
チアジアゾリル酢酸またはその塩の製造方法である。
The present invention has the general formula: [Wherein R 1 represents a lower alkyl group, R 2 represents an amino group which may be protected by a protecting group] or a salt thereof is hydrolyzed in the presence of a base, and a protecting group may be added if necessary. General formula characterized by desorption: [Wherein R 1 and R 2 are the same as defined above], and a process for producing thiadiazolylacetic acid or a salt thereof.

上記反応は,水性溶媒中,塩基の存在下,反応温度0℃
〜80℃,好ましくは45℃〜55℃で行うことができる。保
護基の脱離は,保護基の種類に応じて,常法,例えば加
水分解,還元などの方法により行うことができる。
The above reaction is carried out in an aqueous solvent in the presence of a base at a reaction temperature of 0 ° C.
It can be carried out at -80 ° C, preferably 45 ° C-55 ° C. Removal of the protecting group can be carried out by a conventional method such as hydrolysis or reduction depending on the kind of the protecting group.

塩基としては,水酸化ナトリウム,水酸化カリウム,炭
酸ナトリウム,炭酸カリウム,炭酸水素ナトリウム,炭
酸水素カリウム,酢酸ナトリウム,酢酸カリウムなどを
用いることができる。
As the base, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium acetate, potassium acetate or the like can be used.

水性溶媒としては,水,緩衝液,あるいはこれらとメタ
ノール,エタノールなどの低級アルコールとの混合溶媒
を用いることができる。
As the aqueous solvent, water, a buffer solution, or a mixed solvent thereof with a lower alcohol such as methanol or ethanol can be used.

一般式(I)および(II)の化合物のR1の低級アルキル
基としては,メチル,エチル,n−プロピル,i−プロピ
ル,n−ブチル,t−ブチル,sec−ブチルなどがあげられ
る。また,R2の「保護基で保護されていてもよいアミノ
基」における保護基の種類としては,通常アミノ基の保
護基として知られているものを使用することができる。
例えば,ホルミル,アセチル,クロロアセチル,ジクロ
ルアセチル,プロピオニル,フェノキシアセチルなどの
置換または非置換の低級アルカノイル基;ベンジルオキ
シカルボニル,t−ブトキシカルボニル,p−ニトロベンジ
ルオキシカルボニルなどの置換または非置換の低級アル
コキシカルボニル基;トリチル,p−メトキシベンジル,
ジフェニルメチルなどの置換低級アルキル基;トリメチ
ルシリル,t−ブチルジメチルシリルなどの置換シリル
基;ベンジリデン,サリチリデン,3,5−ジ(t−ブチ
ル)−4−ハイドロキシベンジリデンなどの置換または
非置換のベンジリデン基等があげられる。
Examples of the lower alkyl group for R 1 in the compounds of the general formulas (I) and (II) include methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl, sec-butyl and the like. Further, as the type of the protecting group in the “amino group which may be protected by a protecting group” of R 2 , those generally known as a protecting group for an amino group can be used.
For example, a substituted or unsubstituted lower alkanoyl group such as formyl, acetyl, chloroacetyl, dichloroacetyl, propionyl, and phenoxyacetyl; a substituted or unsubstituted lower alkanoyl group such as benzyloxycarbonyl, t-butoxycarbonyl, p-nitrobenzyloxycarbonyl and the like. Lower alkoxycarbonyl group; trityl, p-methoxybenzyl,
Substituted lower alkyl group such as diphenylmethyl; Substituted silyl group such as trimethylsilyl, t-butyldimethylsilyl; Substituted or unsubstituted benzylidene group such as benzylidene, salicylidene, 3,5-di (t-butyl) -4-hydroxybenzylidene Etc.

一般式(I)の化合物の塩としては,上記の反応を妨げ
ないものであれば使用することができる。例えば塩酸
塩,硫酸塩,炭酸塩,重炭酸塩,臭化水素酸塩,沃化水
素酸塩などの無機酸塩;酢酸塩,マレイン酸塩,乳酸
塩,酒石酸塩,トリフルオロ酢酸塩などの有機カルボン
酸塩;メタンスルホン酸塩,ベンゼンスルホン酸塩,ト
ルエンスルホン酸塩などの有機スルホン酢酸塩;アスパ
ラギン酸塩,グルタミン酸塩などのアミノ酸塩等があげ
られる。
As the salt of the compound of the general formula (I), any salt can be used as long as it does not interfere with the above reaction. For example, inorganic acid salts such as hydrochloride, sulfate, carbonate, bicarbonate, hydrobromide, hydroiodide; acetate, maleate, lactate, tartrate, trifluoroacetate, etc. Organic carboxylic acid salts; methanesulfonic acid salts, benzenesulfonic acid salts, organic sulfonic acid salts such as toluenesulfonic acid salts; amino acid salts such as aspartic acid salts and glutamic acid salts.

また,一般式(II)の化合物の塩としては,例えばナト
リウム塩,カリウム塩などのアルカリ金属塩;カルシウ
ム塩,マグネシウム塩などのアルカリ土類金属塩;アン
モニウム塩;塩酸塩,硫酸塩,炭酸塩,重炭酸塩,臭化
水素塩,沃化水素酸塩などの無機酸塩;酢酸塩,マレイ
ン酸塩,乳酸塩,酒石酸塩,トリフルオロ酢酸塩などの
有機カルボン酸塩;メタンスルホン酸塩,ベンゼンスル
ホン酸塩,トルエンスルホン酸塩などの有機スルホン酸
塩;トリメチルアミン塩,トリエチルアミン塩,ピリジ
ン塩,プロカイン塩,ピコリン塩,ジシクロヘキシルア
ミン塩,N,N′−ジベンジルエチレンジアミン塩,N−メチ
ルグルカミン塩,ジエタノールアミン塩,トリエタノー
ルアミン塩,トリス(ヒドロキシメチルアミノ)メタン
塩などのアミン塩;アルギニン塩,アスパラギン酸塩,
リジン塩,グルタミン酸塩,セリン塩などのアミノ酸塩
等があげられる。
Examples of the salt of the compound of the general formula (II) include alkali metal salts such as sodium salt and potassium salt; alkaline earth metal salts such as calcium salt and magnesium salt; ammonium salt; hydrochloride salt, sulfate salt and carbonate salt. , Inorganic salts such as bicarbonate, hydrobromide, hydroiodide; organic carboxylates such as acetate, maleate, lactate, tartrate, trifluoroacetate; methanesulfonate, Organic sulfonates such as benzene sulfonate and toluene sulfonate; trimethylamine salt, triethylamine salt, pyridine salt, procaine salt, picoline salt, dicyclohexylamine salt, N, N′-dibenzylethylenediamine salt, N-methylglucamine Amine salts such as salts, diethanolamine salts, triethanolamine salts, tris (hydroxymethylamino) methane salts; Arginine salt, aspartate,
Examples thereof include amino acid salts such as lysine salt, glutamate and serine salt.

本発明の原料化合物である一般式(I)の化合物は対応
するチアジアゾリルアセトニトリル誘導体を過酸化水素
等の酸化剤および塩基の存在下で加水分解して得ること
ができる。したがってチアジアゾリルアセトニトリル誘
導体から出発するとすれば,チアジアゾリルアセトニト
リル誘導体よりチアジアゾリルアセトアミド誘導体を
得,ついで加水分解してチアジアゾリル酢酸誘導体を得
るという2段階反応であるが,前に示したチアジアゾリ
ルアセトニトリル誘導体より直接にチアジアゾリル酢酸
誘導体を得る従来法に比べて高収率であり,工業的に優
れた方法である。
The compound of the general formula (I) which is the starting compound of the present invention can be obtained by hydrolyzing the corresponding thiadiazolylacetonitrile derivative in the presence of an oxidizing agent such as hydrogen peroxide and a base. Therefore, starting from a thiadiazolylacetonitrile derivative is a two-step reaction in which a thiadiazolylacetamide derivative is obtained from a thiadiazolylacetonitrile derivative and then hydrolyzed to obtain a thiadiazolylacetic acid derivative. This is an industrially superior method with a higher yield than the conventional method in which a thiadiazolylacetic acid derivative is directly obtained from a rilacetonitrile derivative.

次に実施例および実験例を示し,本発明をさらに詳しく
説明する。
Next, the present invention will be described in more detail by showing Examples and Experimental Examples.

実験例1(原料化合物の製造) 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−(Z)−2−メトキシイミノアセトアミド 水400ml,水酸化ナトリウム10g,35%過酸化水素水160ml
の混合液に2−(5−アミノ−1,2,4−チアジアゾール
−3−イル)−(Z)−2−メトキシイミノアセトニト
リル80gを加え,水冷下で5時間攪拌した。析出物を
取し,水,アセトンで洗浄した後,乾燥して目的物77.7
g(収率88.4%)を得た。
Experimental Example 1 (Production of raw material compound) 2- (5-amino-1,2,4-thiadiazol-3-yl)-(Z) -2-methoxyiminoacetamide Water 400 ml, sodium hydroxide 10 g, 35% hydrogen peroxide water 160 ml
80 g of 2- (5-amino-1,2,4-thiadiazol-3-yl)-(Z) -2-methoxyiminoacetonitrile was added to the mixed solution of, and the mixture was stirred under water cooling for 5 hours. The precipitate is collected, washed with water and acetone, and then dried to obtain the desired product 77.7.
g (yield 88.4%) was obtained.

実験例2(原料化合物の製造) 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−(Z)−2−エトキシイミノアセトアミド 水150ml,水酸化ナトリウム6.0gおよび35%過酸化水素水
30mlの混合溶液にメタノール75mlを加え,室温まで冷却
した。ついでこの溶液に2−(5−アミノ−1,2,4−チ
アジアゾール−3−イル)−(Z)−2−エトキシイミ
ノアセトニトリル15.0gを加え,室温下で約6時間攪拌
した。反応液を10℃まで冷却後,析出物を取し,水,
イソプロピルアルコール,エチルエーテルで洗浄した。
これを乾燥して目的物13.2g(収率80.6%)を得た。
Experimental Example 2 (Production of raw material compound) 2- (5-amino-1,2,4-thiadiazol-3-yl)-(Z) -2-ethoxyiminoacetamide 150 ml water, 6.0 g sodium hydroxide and 35% hydrogen peroxide
75 ml of methanol was added to the 30 ml mixed solution, and the mixture was cooled to room temperature. Then, 15.0 g of 2- (5-amino-1,2,4-thiadiazol-3-yl)-(Z) -2-ethoxyiminoacetonitrile was added to this solution, and the mixture was stirred at room temperature for about 6 hours. After cooling the reaction solution to 10 ° C, the precipitate was removed, water,
It was washed with isopropyl alcohol and ethyl ether.
This was dried to obtain 13.2 g of the desired product (yield 80.6%).

実験例3(原料化合物の製造) 2−(5−クロロアセトアミド−1,2,4−チアジアゾー
ル−3−イル)−(Z)−2−メトキシイミノアセトア
ミド 水100ml,水酸化ナトリウム2.0gおよび35%過酸化水素水
10.0mlの混合溶液に2−(5−クロロアセトアミド−1,
2,4−チアジアゾール−3−イル)−(Z)−2−メト
キシイミノアセトニトリル5.0gを加え,30分間攪拌し
た。反応液を−2℃まで冷却し,析出物を取した。こ
れを氷水,エチルエーテルで洗浄後,乾燥して目的物2.
0gを得た。
Experimental Example 3 (Production of raw material compound) 2- (5-chloroacetamide-1,2,4-thiadiazol-3-yl)-(Z) -2-methoxyiminoacetamide 100 ml of water, 2.0 g of sodium hydroxide and 35% hydrogen peroxide
2- (5-chloroacetamide-1, 10, to a mixed solution of 10.0 ml
5.0 g of 2,4-thiadiazol-3-yl)-(Z) -2-methoxyiminoacetonitrile was added and stirred for 30 minutes. The reaction solution was cooled to −2 ° C. and the precipitate was collected. This is washed with ice water and ethyl ether and then dried to obtain the desired product 2.
I got 0g.

さらに,上記の液を酢酸エチル抽出した。これに無水
硫酸マグネシウムを加えて乾燥した後,酢酸エチルを留
去した。残渣にイソプロピルエーテルを加えて結晶化を
行い,目的物2.2gを得た。
Furthermore, the above liquid was extracted with ethyl acetate. Anhydrous magnesium sulfate was added to this and dried, and then ethyl acetate was distilled off. Isopropyl ether was added to the residue for crystallization to obtain 2.2 g of the desired product.

目的物として合計4.2g(収率78.6%)を得た。A total of 4.2 g (yield 78.6%) was obtained as the target product.

実施例1 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−(Z)−2−メトキシイミノ酢酸 2N水酸化ナトリウム水溶液80mlおよび2−(5−アミノ
−1,2,4−チアジアゾール−3−イル)−(Z)−2−
メトキシイミノアセトアミド4.02gの混合物を50℃で5
時間攪拌した。反応液を10℃まで冷却し,濃塩酸にて溶
液のpHを1に調整した。これを酢酸エチルで抽出し,無
水硫酸マグネシウムを加えて乾燥した。ついでこれを減
圧濃縮した後,濃縮液にイソプロピルエーテル100mlを
滴下した。不溶物を取し,イソプロピルエーテルで洗
浄後,乾燥して目的物3.2g(収率79.2%)を白色粉末と
して得た。純度は,HPLC分析で98.2%であった。
Example 1 2- (5-Amino-1,2,4-thiadiazol-3-yl)-(Z) -2-methoxyiminoacetic acid 80 ml of 2N aqueous sodium hydroxide solution and 2- (5-amino-1,2,4-thiadiazol-3-yl)-(Z) -2-
A mixture of 4.02 g of methoxyiminoacetamide was added at 50 ° C. to 5
Stir for hours. The reaction solution was cooled to 10 ° C, and the pH of the solution was adjusted to 1 with concentrated hydrochloric acid. This was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and dried. Then, this was concentrated under reduced pressure, and 100 ml of isopropyl ether was added dropwise to the concentrated solution. The insoluble material was removed, washed with isopropyl ether, and dried to obtain 3.2 g (yield 79.2%) of the desired product as a white powder. The purity was 98.2% by HPLC analysis.

実験例4(従来法) 2−(5−アミノ−1,2,4−チアジゾール−3−イル)
−(Z)−2−メトキシイミノ酢酸 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−(Z)−2−メトキシイミノアセトニトリル7.50
g,水40mlの懸濁液に,40℃にて,4N水酸化ナトリウム水溶
液95mlを滴下し,50℃〜55℃にて5時間攪拌した。反応
液を10℃に冷却した後,6N塩酸を滴下して溶液のpHを2.4
に調整した。これに酢酸エチル50mlを加えて不純物を抽
出,除去した。水層に6N塩酸を加えてpH0.8に調整した
後,活性炭0.5gを加えて過した。液を酢酸エチルで
抽出し,抽出液に無水硫酸マグネシウムを加えて乾燥し
た。酢酸エチルを減圧留去し,残渣にイソプロピルエー
テル100mlを加え,析出物を取した。これを乾燥し
て,粗製物3.5g(HPLC分析による純度79.5%)を淡黄色
粉末として得た。
Experimental Example 4 (conventional method) 2- (5-amino-1,2,4-thiazizol-3-yl)
-(Z) -2-Methoxyiminoacetic acid 2- (5-amino-1,2,4-thiadiazol-3-yl)-(Z) -2-methoxyiminoacetonitrile 7.50
To 40 g of water and 40 ml of water, 95 ml of 4N aqueous sodium hydroxide solution was added dropwise at 40 ° C, and the mixture was stirred at 50 ° C to 55 ° C for 5 hours. After cooling the reaction solution to 10 ℃, add 6N hydrochloric acid dropwise to adjust the pH of the solution to 2.4.
Adjusted to. 50 ml of ethyl acetate was added to this to extract and remove impurities. After adjusting the pH to 0.8 by adding 6N hydrochloric acid to the aqueous layer, 0.5 g of activated carbon was added and passed. The solution was extracted with ethyl acetate, and anhydrous magnesium sulfate was added to the extract to dry it. Ethyl acetate was evaporated under reduced pressure, 100 ml of isopropyl ether was added to the residue, and the precipitate was collected. This was dried to obtain 3.5 g of a crude product (purity 79.5% by HPLC analysis) as a pale yellow powder.

ついで,この粗製物3.5gに酢酸エチル−メチルエチルケ
トン(1:1)70mlを加え,45℃〜50℃に15分間加熱した。
同温度で過し,酢酸エチル7mlで洗浄し,乾燥して目
的物1.6g(収率19.7%)を白色粉末として得た。HPLC分
析による純度は97.5%であった。
Then, 70 ml of ethyl acetate-methyl ethyl ketone (1: 1) was added to 3.5 g of this crude product, and the mixture was heated at 45 ° C to 50 ° C for 15 minutes.
The mixture was passed at the same temperature, washed with 7 ml of ethyl acetate, and dried to obtain 1.6 g of the desired product (yield 19.7%) as a white powder. The purity by HPLC analysis was 97.5%.

実施例2 2−(5−アミノ−1,2,4−チアジアゾール−3−イ
ル)−(Z)−2−エトキシイミノ酢酸 2N水酸化ナトリウム80mlおよび2−(5−アミノ−1,2,
4−チアジアゾール−3−イル)−(Z)−2−エトキ
シイミノアセトアミド4.0gの混合物を50℃で8時間攪拌
した。反応液を10℃まで冷却し,濃塩酸にて溶液のpHを
1に調整した。これを酢酸エチルで抽出し,無水硫酸マ
グネシウムを加えて乾燥した。ついで減圧濃縮した後,
濃縮液にイソプロピルエーテル100mlを滴下した。不溶
物を取し,イソプロピルエーテルで洗浄後,乾燥して
目的物3.2g(収率80.2%)を白色粉末として得た。
Example 2 2- (5-Amino-1,2,4-thiadiazol-3-yl)-(Z) -2-ethoxyiminoacetic acid 80 ml of 2N sodium hydroxide and 2- (5-amino-1,2,
A mixture of 4-thiadiazol-3-yl)-(Z) -2-ethoxyiminoacetamide (4.0 g) was stirred at 50 ° C for 8 hours. The reaction solution was cooled to 10 ° C, and the pH of the solution was adjusted to 1 with concentrated hydrochloric acid. This was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and dried. Then, after concentration under reduced pressure,
100 ml of isopropyl ether was added dropwise to the concentrated solution. The insoluble material was removed, washed with isopropyl ether, and dried to obtain 3.2 g (yield 80.2%) of the desired product as a white powder.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 杉山 功 茨城県筑波郡谷田部町東荒井29−4 審査官 池田 正人 ─────────────────────────────────────────────────── --- Continuation of the front page (72) Inventor Isao Sugiyama 29-4 Higashiarai, Yatabe-cho, Tsukuba-gun, Ibaraki Examiner Masato Ikeda

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式: 〔式中,R1は低級アルキル基,R2は保護基で保護されて
いてもよいアミノ基を示す〕で表わされる化合物または
その塩を塩基の存在下で加水分解し,必要により保護基
を脱離することを特徴とする一般式: 〔式中,R1およびR2は前記の定義に同じ〕で表わされる
チアジアゾリル酢酸またはその塩の製造方法。
1. A general formula: [Wherein R 1 represents a lower alkyl group, R 2 represents an amino group which may be protected by a protecting group] or a salt thereof is hydrolyzed in the presence of a base, and a protecting group may be added if necessary. General formula characterized by desorption: [Wherein R 1 and R 2 are the same as defined above], and a process for producing thiadiazolylacetic acid or a salt thereof.
JP12923486A 1986-06-05 1986-06-05 Method for producing thiadiazolylacetic acid Expired - Lifetime JPH0755941B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12923486A JPH0755941B2 (en) 1986-06-05 1986-06-05 Method for producing thiadiazolylacetic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12923486A JPH0755941B2 (en) 1986-06-05 1986-06-05 Method for producing thiadiazolylacetic acid

Publications (2)

Publication Number Publication Date
JPS62286979A JPS62286979A (en) 1987-12-12
JPH0755941B2 true JPH0755941B2 (en) 1995-06-14

Family

ID=15004490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12923486A Expired - Lifetime JPH0755941B2 (en) 1986-06-05 1986-06-05 Method for producing thiadiazolylacetic acid

Country Status (1)

Country Link
JP (1) JPH0755941B2 (en)

Also Published As

Publication number Publication date
JPS62286979A (en) 1987-12-12

Similar Documents

Publication Publication Date Title
EP0438314B1 (en) Process for the production of 3-(1-amino-1,3-dicarboxy-3-hydroxy-but-4-yl) indole
KR20040043169A (en) Process for the production of beraprost and its salts
US6197969B1 (en) Process for producing substituted alkylamines or salts thereof
US4690921A (en) Cephalosporin compounds and salts thereof
JPH0755941B2 (en) Method for producing thiadiazolylacetic acid
JP2864475B2 (en) Method for producing 2-phenylbenzotriazoles
HU213315B (en) Process for producing arylacetic acids and their alkali metal salts
US20220324839A1 (en) Process for preparing pyrimidinyl bipyridine compound and intermediate therefor
JPS6340424B2 (en)
EP0248434B1 (en) Thiadiazolylacetamide derivatives, process for the preparation thereof and their use
KR950001026B1 (en) Process for preparing penicillanic acid derivatives
KR950010597B1 (en) Process for the preparation of cephalosporin derivatives
EP0066440B1 (en) Chemical process
US6090168A (en) Processes and intermediates useful to make antifolates
FR2574792A1 (en) PROCESS FOR THE PREPARATION OF PYRROLIDINE DERIVATIVES
CA1296343C (en) [(2,2,2-trichloroethoxy)methoxy)]amine
KR890002253B1 (en) Process for preparing thiazole compound
US7122674B2 (en) Process for preparing high-purity hydroxyindolylglyoxylamides
KR820001613B1 (en) Process for the preparation of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate
EP0003847A1 (en) Biphenylylglycine derivatives and their salts with bases
KR900003407B1 (en) Silyl compound and preparation method thereof
JPH01143847A (en) Separation and purification of 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid ester
KR880001761B1 (en) Process for preparing intermediate products for the preparation of cepharosporins
JPS6287599A (en) Production of oxime derivative of erythromycin
KR810000802B1 (en) Preparing process for 4-benzoyl pyrazol derivatives and its aluminum salts